Starting a regulated startup is fundamentally different from starting a software company or another business that can launch quickly, acquire users, and begin generating revenue within months. If you are building a medical device, drug, diagnostic, biotech product, or another regulated technology, your path to market may take years. You may need to work through regulators, manufacturers, clinicians, testing partners, quality systems, and investors long before your first customer can ever buy the product.
I learned this firsthand while building a drug-device startup as a student. Our product was regulated as a drug delivered through a device, which put us on roughly an eight-year path to market. Despite being years away from commercialization, I was able to raise more than $250,000 in non-dilutive funding and get close to half a million dollars in pre-seed commitments while owning the technology completely, without university or outside organizational ownership.
The biggest lesson was that you cannot build a regulated startup exactly the same way you build something that can immediately be put in customers’ hands. When you cannot point to revenue, thousands of users, or rapid month-over-month growth, you have to create credibility in other ways. Customer discovery, prototypes, technical progress, intellectual property, regulatory clarity, advisers, development partners, and evidence that people actually want what you are building all become different forms of traction.
1. Validate the Problem Long Before You Can Sell the Product
One of the biggest misconceptions I see with regulated startups is that founders think they cannot meaningfully validate the business until the product is finished. In reality, customer discovery may be even more important for a regulated company precisely because you cannot rely on sales to tell you whether you are building something people actually want.
At the beginning, your goal should still be to understand the problem before becoming attached to your solution. Talk to the people experiencing it. Understand how they solve it today, what frustrates them, how often the problem occurs, what it costs them, and what would actually cause them to change their behavior. As I go into much more deeply in Customer Discovery That Actually Gets You Money, the goal early on is not to convince people that your idea is great. It is to gather enough independent evidence to determine whether the problem is actually worth solving.
As your product becomes more developed, you can start validating the proposed solution even if regulations prevent someone from actually using the finished product. Depending on what you are building, that might mean showing potential customers:
Renderings or CAD models
Early or nonfunctional prototypes
Images, diagrams, or infographics
Videos and animations
Different product configurations
Examples of how the product would work or be used
For my company, this became extremely important. We conducted hundreds of conversations with patients, providers, and other stakeholders even though we were years away from commercialization. We could show people the concept, compare different configurations, understand which features mattered, measure preference, and determine what would make someone switch from the products they already used. You are not claiming that someone has validated a product they have never actually used. You are progressively moving from problem validation toward solution validation while being honest about what each stage actually proves.
That evidence becomes especially useful when you walk into a pitch competition or investor meeting with no revenue. Instead of saying, “Trust me, people will want this in eight years,” you can show that you have spoken to hundreds of relevant stakeholders, explain what they consistently told you, and demonstrate exactly how those conversations changed what you are building.
2. Understand That Traction Looks Different in a Regulated Company
This is one of the hardest things about fundraising for a regulated startup. A SaaS company might be able to point to growing revenue, active users, retention, or pilots within months. A regulated company may still be several years away from having any of those metrics.
That does not mean you have no traction. It means you need to build a different body of evidence.
For an early regulated startup, traction might include strong customer validation, intellectual property, prototypes, technical data, regulatory progress, letters of intent, respected advisers, grant funding, development partnerships, or demonstrated interest from clinicians and strategic organizations. None of these individually proves that your company will succeed, but together they can show that the company is becoming progressively less risky.
This also makes pitch competitions more difficult in some ways. Judges naturally understand a company that can say, “We launched six months ago and have $100,000 in revenue.” Your job is to make your evidence just as easy to understand. When I was competing while years away from launch, customer discovery, prototypes, advisers, and evidence of technical and market progress became a major part of how I established credibility. I go deeper into that in How to Win a Pitch Competition.
The broader idea is simple: when you cannot show traditional traction yet, show de-risking. Investors and judges need to see that you know what the major uncertainties are and that the company is systematically eliminating them.
3. Figure Out the Road to Market Earlier Than You Think
You do not need to become a regulatory expert yourself, but one of the most expensive mistakes you can make is building for years before understanding what actually has to happen before the product can be sold.
At a basic level, you should start determining which regulator has authority over your product, how it is likely to be classified, what approval or clearance pathway may apply, what evidence will eventually be required, and what claims you ultimately want to make. If you are in healthcare, that could mean understanding whether you are developing a device, drug, biologic, diagnostic, combination product, or something else entirely.
The important point is that the regulatory pathway should inform development rather than being something you think about after development.
Instead of thinking:
Build the product → send it to the regulator → get approval.
Think more like:
Intended use and claims → regulatory pathway → evidence requirements → development plan → testing → quality/documentation → submission → commercialization.
You will not have all of this perfectly mapped when you are starting out, and you should not make final regulatory determinations without people who actually know what they are doing. But you should understand the major path early enough that you are not spending time and money creating something that cannot support the evidence or claims you eventually need.
This is also where talking to specialized development partners early can save you an enormous amount of time. Manufacturers, regulatory consultants, testing laboratories, engineering firms, clinical partners, quality specialists, and other vendors can help you understand what needs to happen first, what work can happen in parallel, what different stages cost, and which mistakes founders commonly make. You do not need to hire every one of them immediately. Sometimes a few early conversations are enough to completely change your development plan.
4. Build the Right Prototype for the Stage You Are Actually In
Student founders often think the first objective is to build something as close as possible to the eventual commercial product. That can be a very expensive mistake.
Different prototypes should answer different questions.
An early prototype may exist simply to communicate the concept, test ergonomics, conduct customer discovery, demonstrate basic functionality, win a competition, attract advisers, or help investors understand what you are building. That prototype may be incredibly valuable even if it could never be used in formal regulatory testing or sold commercially.
The important thing is knowing what your prototype actually proves.
A prototype made from off-the-shelf components may prove that a mechanism works. A 3D-printed model may help you determine whether users like a form factor. A polished appearance model may help an investor finally understand the product. None of those automatically proves that the product can be manufactured at scale, meets regulatory requirements, or will perform safely in its intended use.
I cover the earlier-stage side of this in How to Build Your First Prototype Without Spending a Fortune. The main lesson for regulated founders is to avoid spending commercial-product money to answer prototype-stage questions. Build the cheapest version that can reliably answer the question in front of you.
5. Surround Yourself With People Who Have Already Done It
If you are twenty years old and telling an investor that you plan to take a regulated medical product through an eight-year development pathway, there is an obvious credibility problem.
You probably have not done it before.
I had not either.
Trying to pretend otherwise is not the solution. The solution is surrounding yourself with people who have done it.
For a drug-device company like mine, I wanted experience around areas such as:
Regulatory strategy
Clinical development
Product development and commercialization
Manufacturing and quality
Fundraising and company building
Direct expertise in the disease and patient population
Your advisers matter for two reasons. First, they help you make better decisions. Someone who has commercialized a similar product can often see a mistake coming long before you do. Second, their involvement creates credibility. When someone with twenty years of industry experience, successful product launches, or previous exits is willing to put their time and reputation behind a student founder, investors and judges notice.
That is why I view advisers as part of the infrastructure of an early regulated company rather than decoration for a team slide. I go much deeper into finding, approaching, and actually using them in How to Find Advisors Who Actually Make a Difference.
The same idea applies to the broader network around the company. Your early team may technically be two founders, but the company could function through a much larger network of advisers, engineering firms, manufacturers, regulatory specialists, attorneys, clinicians, and testing partners. One of the most valuable questions you can continually ask is:
Who has already solved the problem I am about to encounter?
Then go find them. The Best Connections to Make First is a good place to start if you are still building that network.
6. Protect the Technology, but Do Not Confuse IP With a Business
Intellectual property can be particularly important in regulated industries because investors may be putting money into your company years before there is significant revenue. If a large part of the company's eventual value comes from proprietary technology, you should understand what is actually protectable, document your work carefully, and think about protection before making important public disclosures.
At the same time, do not let patents become a substitute for validation.
“Patent pending” does not mean customers want the product. It does not prove the technology works. It does not provide regulatory clearance. It does not prove somebody can manufacture it at a viable cost.
A patent protects an invention. That can be enormously valuable, but it is one piece of the company.
I already have a full guide on How to Start Protecting Your Idea for Under $100, including how I approached provisional applications, documentation, timing, and the point at which professional counsel becomes much more valuable. For this article, the important lesson is simply to think about IP early enough that you do not accidentally give away something important while you are validating and pitching the business.
7. Raise Around De-Risking Milestones, Not Just Runway
Fundraising for a regulated company becomes much easier to understand when you stop thinking about money as “how long can this keep us alive?” and start thinking about it as “what uncertainty will this money remove?”
Before raising a round, you should be able to explain what the capital allows you to accomplish and why completing those milestones makes the next version of the company more valuable or less risky.
Maybe the round gets you through a major technical feasibility study. Maybe it produces regulatory data. Maybe it gets you to a testable prototype, a manufacturing milestone, an FDA interaction, or a clinical study.
The specific milestone is different for every company. The important part is that investors can understand:
Here is what we know today → here is what remains uncertain → here is what this capital proves next.
This was especially important for me because investors were looking at a company where a potential return was years away and significant development and regulatory risk still stood between us and commercialization. I could not simply point to revenue growth. I had to show why the problem mattered, why the technology could solve it, who believed in it, and how we were reducing risk one milestone at a time. That's a big part of what I cover in When to Approach Investors—and How to Actually Find Them.
One of my favorite questions to ask investors early is:
“What milestones would you need to see from a company like this before you would seriously consider investing?”
If three relevant investors independently give you roughly the same answer, pay attention. You have just learned what the capital market wants you to prove.
And start those conversations before you desperately need money. Regulated companies can take a long time to diligence, and investors may want to watch you execute before writing a check. A “too early” investor today can become an investor later if you keep them updated and actually hit the milestones you told them you would.
8. Use Being a Student as an Advantage
Building something regulated while you are in school can feel like a disadvantage because you are young, inexperienced, and surrounded by founders building things that may reach customers much faster.
But being a student gives you access to resources that become much harder to access after graduation.
Universities can provide grants, pitch competitions, mentors, professors, physicians, alumni, prototyping facilities, entrepreneurship programs, technical experts, and introductions to investors. I personally used university-linked opportunities to bring in meaningful non-dilutive capital and build parts of my adviser network while still keeping ownership of my technology outside the university.
The important distinction is that using university resources does not automatically mean your company should become university-owned technology. Understand the IP policies around laboratories, sponsored research, faculty involvement, and university resources before assuming anything. I cover this much more extensively in How to Use Your University to Build Your Startup, which is also in the Student Founder Playbook.
Use the university aggressively where it helps you. Just understand the rules before you build something valuable inside a structure you have not read.
9. What I Would Do Differently
There are plenty of things I would do differently if I started another regulated company tomorrow.
I would speak with regulatory and development specialists earlier, get multiple quotes for major scopes of work, and understand exactly what each proposal included before committing capital. I would build more time into every development schedule because almost everything takes longer than the clean timeline in your pitch deck. I would also start investor relationships earlier and think much more carefully about whether each round of capital was large enough to reach a milestone that the next group of investors would actually value.
I would also be much stricter about distinguishing different types of progress. A patent is progress. A prototype is progress. A respected adviser joining the company is progress. A customer saying they love the concept is progress. None of those individually means the company has been fully de-risked.
Regulated startups are difficult because you have to stack many different kinds of evidence over a long period of time. You are trying to prove that the problem exists, people want your solution, the technology works, the product can be manufactured, the regulator has a viable pathway for it, the economics can make sense, and your team can actually execute the plan.
You do not have to prove all of that on day one.
You need to know what the next biggest uncertainty is and what you can do to reduce it.
That is probably the biggest lesson I took away from building one.
The Biggest Takeaway
You do not need millions of dollars, a finished regulatory strategy, or a commercial-ready product before starting a regulated company as a student.
You do need to understand that the game is different.
You may not be able to use revenue as proof yet, so prove demand through serious customer discovery. You may not personally have decades of industry experience, so surround yourself with people who do. You may not know every regulatory requirement, so find experts and development partners early enough that you can build the right roadmap. And when you raise money, make sure you know exactly what new evidence that money is supposed to create.
The goal is not to remove every risk at once. It is to understand the road ahead and remove the most important risk one milestone at a time.